Neurobehavioral Disorders
Novel Combination Therapy for Major Depressive Disorder Gets Priority Review
AXS-05 consists of dextromethorphan, an NMDA receptor antagonist, and bupropion, a norepinephrine and dopamine reuptake inhibitor.
Your search for major depressive disorder returned 95 results
Multiple Sclerosis
Multiple Sclerosis and Major Depressive Disorder Share Little Genetic Liability
A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.
Neurobehavioral Disorders
Over Half Have Symptoms of Major Depressive Disorder After COVID-19
More than half of individuals with prior COVID-19 illness have met the criteria for symptoms of major depressive disorder.
Neurobehavioral Disorders
Functional Connectome Fingerprints Provide Clues to Major Depressive Disorder
The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.
Neurobehavioral Disorders
Anxiety Symptoms with Major Depressive Disorder Reduce with Repetitive Transcranial Magnetic Stimulation
The researchers analyzed data from a large randomized noninferiority trial that compared theta-burst stimulation and high-frequency (10 Hz) rTMS delivered to the left dorsolateral prefrontal cortex.
Neurobehavioral Disorders
Individuals With Major Depressive Disorder May Have a Genetic Liability Which Increases Risk for Opioid Use
This study addresses the question of whether prescription opioid medications has a potentially causal role in the risk for depression and anxiety disorder.
Neurobehavioral Disorders
Impact of Serial Ketamine Infusions on Resting-State Functional Connectivity in Major Depressive Disorder
Investigating whether serial ketamine treatments change functional connectivity between limbic structures and resting-state networks.
Neurobehavioral Disorders
Gamma Transcranial Alternating Current Stimulation and Mood, Cognition in Major Depressive Disorder
Patients received 40 Hz gamma tACS to provide data on the use of varying stimulation periods.
Neurobehavioral Disorders
Cognition Kit DSST App Validated for Measuring Major Depressive Disorder
Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.
Neurobehavioral Disorders
Pimavanserin Effective for Depression in Parkinson Disease, Major Depressive Disorder
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
- Loading...
Loading...
Next post in Neurobehavioral Disorders
Loading... 
Loading...